Science 37 rode the trends of Covid-19 technologies and SPAC mergers to a more than $1 billion valuation. But revenue for the decentralized clinical trials software firm stopped growing, and it’s now going private valued at just $38 million.
Read about news from healthcare startups Bright.MD, Science 37, NexEos Bio and more.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Science 37, a telehealth company that facilitates virtual clinical trials, struck a partnership with data analytics company AiCure to better track how patients are responding to treatment.
Judy Smythe, Bardia Akbari and Niv Caviar have been named as the company's chief operating officer, senior vice president of clinical operations and chief financial officer, respectively.
The goal is to increase patient and physician awareness and education on clinical trials in dermatology and reduce the often time-consuming process of clinical trial recruitment.
Between 2006 and 2016, the total number of registered clinical trials increased by 650 percent. To successfully recruit and run all of those studies today, something needs to change.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
If you're not quite sure what healthcare "convergence" truly means and achieves, take a look at Science 37 and its four-pronged approach to modernizing clinical trials.
Science 37 illustrated a way forward for pharma companies to improve clinical trial recruitment through social media and remote monitoring, reducing drug development costs.